Insights on Discovery

  1. Ushering In A New Era Of Human-Relevant Drug Discovery 7/29/2026

    With most drug candidates failing before approval, researchers need better ways to predict human responses. Gain insight into how advances in human-relevant modeling are helping improve decisions.

  2. How Organ-Chips Are Transforming Women's Reproductive Health Research 7/29/2026

    Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

  3. Addressing Gaps In The CGT Market Through Partnership 7/27/2026

    Reducing variability is critical to advancing cell therapy development. Learn how cell sourcing, quality-focused manufacturing strategies, and ecosystem partnerships can support reproducible research.

  4. How Isogenic Organ-Chips Are Transforming The Future Of Research 6/25/2026

    Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.

  5. A Timeline Of U.S. Actions To Reduce Animal Models In Research 6/25/2026

    Policy and scientific validation have aligned to shift drug development beyond animal models. New regulations and technologies are making human‑relevant methods the standard for preclinical research.

  6. mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models 6/19/2026

    Repeat dosing may be essential for long-term mRNA applications. Explore safety, immune-response, and efficacy findings from multiple LNP administrations, including a nine-dose evaluation over six months.

  7. CRISPR Reagents Enable High Efficiencies Of Editing And HDR In iPSCs 6/15/2026

    Achieving consistent Homology Directed Repair (HDR) in iPSCs requires optimized CRISPR design and workflows. See how advanced reagents and targeted enhancement strategies improve insertion efficiency.

  8. CAR Detection Reagents - Applications For Flow Cytometry 6/11/2026

    Precise detection of CAR T cells supports reliable analysis and imaging across workflows. See how flexible reagent strategies reduce background, improve specificity, and enable deeper insight.

  9. Closing The QC Gap For mAbs: Rapid Answers Without Compromising 6/9/2026

    Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

  10. Designing RNase H1 "Gapmer" Antisense Oligonucleotides 6/9/2026

    Effective RNA-targeting oligonucleotide design hinges on balancing affinity, stability, and selectivity. Explore how chemical modifications, sequence choices, and delivery approaches influence potency.